You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Drugs Containing Excipient (Inactive Ingredient) NONCRYSTALLIZING SORBITOL SOLUTION


✉ Email this page to a colleague

« Back to Dashboard


Generic drugs containing NONCRYSTALLIZING SORBITOL SOLUTION excipient

NONCRYSTALLIZING SORBITOL SOLUTION Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Noncrystallizing Sorbitol Solution

Introduction to Noncrystallizing Sorbitol Solution

Noncrystallizing sorbitol solution, a form of the polyol sorbitol, is a versatile and widely used pharmaceutical excipient. It is known for its multifunctional properties, including its role as a sweetener, humectant, and stabilizer in various pharmaceutical formulations.

Global Market Size and Growth

The global sorbitol market, which includes noncrystallizing sorbitol, was valued at USD 1.66 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 6.7% from 2023 to 2030[4].

Segment-Specific Growth

Within the sorbitol market, noncrystallizing sorbitol constitutes a significant share due to its broad applications across various industries. The global Sorbitol 70 percent market, which includes noncrystallizing sorbitol, is estimated to be USD 1854.5 million in 2024 and is expected to grow at a CAGR of 5.5% from 2024 to 2031[1].

Regional Market Dynamics

North America

North America leads the Sorbitol 70 percent market, holding more than 40% of the global revenue with a market size of USD 741.8 million in 2024. This region is expected to grow at a CAGR of 3.7% from 2024 to 2031. The robust demand from the food and beverage industries, along with the pharmaceutical sector, drives this growth[1].

Europe

Europe holds around 30% of the global Sorbitol 70 percent market revenue, with a market size of USD 556.35 million in 2024. The region is anticipated to grow at a CAGR of 4.0% from 2024 to 2031. Health and wellness trends among European consumers contribute to the demand for low-calorie sweeteners like sorbitol[1].

Asia Pacific

The Asia Pacific region, though smaller in the Sorbitol 70 percent market with around 23% of the global revenue (USD 426.54 million in 2024), is expected to grow at a higher CAGR of 7.5% from 2024 to 2031. This rapid growth is driven by increasing health-conscious consumers and the expanding consumer markets in the region[1].

Applications in the Pharmaceutical Industry

Functions as an Excipient

Sorbitol is extensively used in the pharmaceutical industry due to its multifunctional properties. It acts as a sweetener, humectant, and stabilizer in oral liquid formulations, tablets, and capsules. Additionally, it serves as a vehicle for drug delivery in chewable tablets and lozenges. Its non-cariogenic and osmotic properties make it suitable for use in oral care products[3].

Stability and Manufacturability

Pharmaceutical formulators emphasize the stability and manufacturability of sorbitol. It must remain stable under storage conditions and contribute to the overall manufacturability of the product, including ease of processing, blending, and compressibility for solid dosage forms[3].

Drivers of Market Growth

Increasing Demand for Low-Calorie Sweeteners

The growing demand for low-calorie and sugar-free products drives the market for sorbitol. Consumers increasingly prefer dietetic and diabetic food and beverages, which has led to a significant rise in the demand for sorbitol as a substitute for sugar[1][4].

Expansion of Pharmaceutical and Personal Care Industries

The pharmaceutical industry's need for innovative excipients to enhance drug formulations, particularly for chronic diseases, fuels the demand for sorbitol. Its use in personal care products, especially in oral care, due to its non-cariogenic properties, further supports market growth[2][4].

Regulatory Approvals

Approval from regulatory bodies such as the FDA and the U.S. Department of Agriculture (USDA) for the use of sorbitol in medicines and food products enhances its market credibility and drives demand[4].

Key Market Players

The global sorbitol market includes key players such as Ingredion Incorporated, Tereos, SPI Pharma, Roquette Frères, Qinhuangdao Lihua Starch Co., Ltd., Ecogreen Oleochemicals GmbH, Merck KGaA, Gulshan Polyols Ltd., DuPont, Cargill Incorporated, ADM, and American International Foods, Inc. These companies leverage their expertise and resources to drive innovation and sustainability in sorbitol production[4].

Financial Trajectory

Revenue Projections

The global Sorbitol 70 percent market is projected to grow from USD 1854.5 million in 2024 to reach a significant figure by 2031, driven by a CAGR of 5.5%[1].

Regional Revenue Contributions

  • North America: Expected to grow from USD 741.8 million in 2024 at a CAGR of 3.7%[1].
  • Europe: Expected to grow from USD 556.35 million in 2024 at a CAGR of 4.0%[1].
  • Asia Pacific: Expected to grow from USD 426.54 million in 2024 at a CAGR of 7.5%[1].

Conclusion

The market for noncrystallizing sorbitol solution is poised for significant growth driven by increasing demand from the pharmaceutical, food, and beverage industries. The global market size, regional dynamics, and applications of sorbitol highlight its critical role as a versatile excipient.

Key Takeaways

  • The global Sorbitol 70 percent market is valued at USD 1854.5 million in 2024 and is expected to grow at a CAGR of 5.5% from 2024 to 2031.
  • North America leads the market, followed by Europe and the Asia Pacific.
  • Sorbitol's multifunctional properties make it a crucial excipient in pharmaceutical formulations.
  • Growing demand for low-calorie sweeteners and expansion of the pharmaceutical and personal care industries drive market growth.
  • Key market players are driving innovation and sustainability in sorbitol production.

FAQs

What is the current market size of the global Sorbitol 70 percent market?

The global Sorbitol 70 percent market size is estimated at USD 1854.5 million in 2024[1].

What is the expected CAGR for the global Sorbitol 70 percent market from 2024 to 2031?

The global Sorbitol 70 percent market is expected to grow at a CAGR of 5.5% from 2024 to 2031[1].

Which region dominates the Sorbitol 70 percent market?

North America dominates the Sorbitol 70 percent market, holding more than 40% of the global revenue[1].

What are the primary applications of noncrystallizing sorbitol in the pharmaceutical industry?

Noncrystallizing sorbitol is used as a sweetener, humectant, and stabilizer in oral liquid formulations, tablets, and capsules, and as a vehicle for drug delivery in chewable tablets and lozenges[3].

Who are the key players in the global sorbitol market?

Key players include Ingredion Incorporated, Tereos, SPI Pharma, Roquette Frères, Qinhuangdao Lihua Starch Co., Ltd., and others[4].

Sources

  1. Cognitive Market Research: Sorbitol 70 percent Market Report 2024 (Global Edition)
  2. BCC Research: Understanding the Future of Pharmaceutical Excipients
  3. Pharma Excipients: Sorbitol as Pharmaceutical Excipient
  4. Grand View Research: Sorbitol Market Size, Share, Trends & Growth Report, 2030
  5. The Business Research Company: Organic Pharmaceutical Excipients Global Market Report 2024

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.